Optomed Oyj (HEL:OPTOMED)
Finland · Delayed Price · Currency is EUR 4.615
+0.115 (2.56%)
Aug 1, 2025, 6:29 PM EET
Verve Therapeutics Market Cap
Optomed Oyj has a market cap or net worth of €90.72 million as of August 1, 2025. Its market cap has decreased by -19.41% in one year.
Market Cap
90.72M
Enterprise Value
84.55M
Revenue
15.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.62
Market Cap Chart
Since December 5, 2019, Optomed Oyj's market cap has increased from 60.42M to 90.72M, an increase of 50.16%. That is a compound annual growth rate of 7.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 90.72M | -0.97% |
| Dec 30, 2024 | 91.61M | 38.72% |
| Dec 29, 2023 | 66.04M | 9.08% |
| Dec 30, 2022 | 60.54M | -54.37% |
| Dec 30, 2021 | 132.68M | 38.93% |
| Dec 30, 2020 | 95.50M | 14.18% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Orion Oyj | 9.94B |
| Terveystalo Oyj | 1.35B |
| Revenio Group Oyj | 714.30M |
| Pihlajalinna Oyj | 368.67M |
| Oriola Oyj | 200.81M |
| Nightingale Health Oyj | 149.67M |
| Nexstim | 108.82M |
| Aiforia Technologies Oyj | 106.20M |